Literature DB >> 29334886

Factors associated with recent unsuppressed viral load in HIV-1-infected patients in care on first-line antiretroviral therapy in South Africa.

D Joseph Davey1,2,3, Z Abrahams2, M Feinberg1, M Prins1, C Serrao1, B Medeossi1, E Darkoh1.   

Abstract

Unsuppressed viral load (VL) in patients on antiretroviral therapy (ART) occurs when treatment fails to suppress a person's VL and is associated with decreased survival and increased HIV transmission. The objective of this study was to evaluate factors associated with unsuppressed VL (VL > 400 copies/ml) in patients currently in care on first-line ART for ≥ 6 months attending South African public healthcare facilities. We analysed electronic medical records of ART patients with a VL result on record who started ART between January 2004 and April 2016 from 271 public health facilities. We present descriptive and multivariable logistic regression for unsuppressed VL at last visit using a priori variables. We included 244,370 patients (69% female) on first-line ART in April 2016 for ≥ 6 months. Median age at ART start was 33 years (7% were < 15 years old). Median duration on ART was 3.7 years. Adjusting for other variables, factors associated with having an unsuppressed VL at the most recent visit among patients in care included: (1) < 15 years old at ART start (adjusted odds ratio [aOR]=2.58; 95% CI = 2.37, 2.81) versus 15-49 years at ART start, (2) male gender (aOR = 1.29; 95% CI = 1.25, 1.35), (3) 6-12 months on ART versus longer (aOR = 1.34; 95% CI = 1.29, 1.40), (4) on tuberculosis (TB) treatment (aOR = 1.78; 95% CI = 1.48, 2.13), and (5) prior ART exposure versus none (aOR = 1.20; 95% CI = 1.08, 1.32). Approximately 85% of the ART cohort who were in care had achieved viral suppression, though men, youth/adolescents, patients with prior ART exposure, those with short duration of ART, and patients on TB treatment had increased odds of not achieving viral suppression. There is a need to develop and evaluate targeted interventions for ART patients in care who are at high risk of unsuppressed VL.

Entities:  

Keywords:  90–90–90; AIDS; HIV; South Africa; antiretroviral therapy; viral load; viral load suppression

Mesh:

Substances:

Year:  2018        PMID: 29334886      PMCID: PMC7053422          DOI: 10.1177/0956462417748859

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  21 in total

1.  Associations with virologic treatment failure in adults on antiretroviral therapy in South Africa.

Authors:  Mohammed Ishaaq Datay; Andrew Boulle; David Mant; Patricia Yudkin
Journal:  J Acquir Immune Defic Syndr       Date:  2010-08       Impact factor: 3.731

Review 2.  Moving forward with treatment options for HIV-infected children.

Authors:  Jean-Christophe Beghin; Jean Cyr Yombi; Jean Ruelle; Dimitri Van der Linden
Journal:  Expert Opin Pharmacother       Date:  2017-09-18       Impact factor: 3.889

3.  Progress with Scale-Up of HIV Viral Load Monitoring - Seven Sub-Saharan African Countries, January 2015-June 2016.

Authors:  Shirley Lecher; Jason Williams; Peter N Fonjungo; Andrea A Kim; Dennis Ellenberger; Guoqing Zhang; Christiane Adje Toure; Simon Agolory; Georgette Appiah-Pippim; Suzanne Beard; Marie Yolande Borget; Sergio Carmona; Geoffrey Chipungu; Karidia Diallo; Marie Downer; Dianna Edgil; Holly Haberman; Mackenzie Hurlston; Steven Jadzak; Charles Kiyaga; William MacLeod; Boniface Makumb; Hellen Muttai; Christina Mwangi; Jane W Mwangi; Michael Mwasekaga; Mary Naluguza; Lucy W Ng'Ang'A; Shon Nguyen; Souleymane Sawadogo; Katrina Sleeman; Wendy Stevens; Joel Kuritsky; Shannon Hader; John Nkengasong
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-12-02       Impact factor: 17.586

4.  Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa.

Authors:  Andrew Boulle; Gilles Van Cutsem; Katherine Hilderbrand; Carol Cragg; Musaed Abrahams; Shaheed Mathee; Nathan Ford; Louise Knight; Meg Osler; Jonny Myers; Eric Goemaere; David Coetzee; Gary Maartens
Journal:  AIDS       Date:  2010-02-20       Impact factor: 4.177

Review 5.  Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis.

Authors:  Suzanna Attia; Matthias Egger; Monika Müller; Marcel Zwahlen; Nicola Low
Journal:  AIDS       Date:  2009-07-17       Impact factor: 4.177

Review 6.  Prevention of mother-to-child transmission in South Africa: an ever-changing landscape.

Authors:  Rosie Burton; Janet Giddy; Kathryn Stinson
Journal:  Obstet Med       Date:  2015-02-06

7.  Rates and predictors of failure of first-line antiretroviral therapy and switch to second-line ART in South Africa.

Authors:  Matthew P Fox; Gilles Van Cutsem; Janet Giddy; Mhairi Maskew; Olivia Keiser; Hans Prozesky; Robin Wood; Miguel A Hernán; Jonathan A C Sterne; Matthias Egger; Andrew Boulle
Journal:  J Acquir Immune Defic Syndr       Date:  2012-08-01       Impact factor: 3.731

8.  Long-Term Outcome of an HIV-Treatment Programme in Rural Africa: Viral Suppression despite Early Mortality.

Authors:  Roos E Barth; Hugo A Tempelman; Robert Moraba; Andy I M Hoepelman
Journal:  AIDS Res Treat       Date:  2010-11-21

9.  Systematic review and meta-analysis of the adolescent HIV continuum of care in South Africa: the Cresting Wave.

Authors:  Brian C Zanoni; Moherndran Archary; Sarah Buchan; Ingrid T Katz; Jessica E Haberer
Journal:  BMJ Glob Health       Date:  2016-10-24

10.  Effectiveness of non-nucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in women previously exposed to a single intrapartum dose of nevirapine: a multi-country, prospective cohort study.

Authors:  Jeffrey S A Stringer; Michelle S McConnell; James Kiarie; Omotayo Bolu; Thanomsak Anekthananon; Tavatchai Jariyasethpong; Dara Potter; Winnie Mutsotso; Craig B Borkowf; Dorothy Mbori-Ngacha; Peter Muiruri; John Odero Ong'ech; Isaac Zulu; Lungowe Njobvu; Bongkoch Jetsawang; Sonal Pathak; Marc Bulterys; Nathan Shaffer; Paul J Weidle
Journal:  PLoS Med       Date:  2010-02-16       Impact factor: 11.069

View more
  25 in total

1.  Development and Validation of a Risk Prediction Tool to Identify People with HIV Infection Likely Not to Achieve Viral Suppression.

Authors:  Merhawi T Gebrezgi; Kristopher P Fennie; Diana M Sheehan; Boubakari Ibrahimou; Sandra G Jones; Petra Brock; Robert A Ladner; Mary Jo Trepka
Journal:  AIDS Patient Care STDS       Date:  2020-04       Impact factor: 5.078

2.  The Frequency and Predictors of Unsuppressed HIV Viral Load Among People with HIV in Nyaruguru District, Rwanda.

Authors:  François Hakizayezu; Emmanuel Biracyaza; Hosee Niyompano; Aline Umubyeyi
Journal:  HIV AIDS (Auckl)       Date:  2022-08-12

3.  Unsuppressed Viral Load Level in Public Health Facilities: Nonvirological Predictors among Adult Antiretroviral Therapy Users in Southwestern Ethiopia.

Authors:  Birhanu Waju; Lamessa Dube; Muktar Ahmed; Semira Shimeles Assefa
Journal:  HIV AIDS (Auckl)       Date:  2021-05-14

4.  Factors associated with viral non-suppression among adolescents living with HIV in Cambodia: a cross-sectional study.

Authors:  Kolab Chhim; Gitau Mburu; Sovannary Tuot; Ratana Sopha; Vohith Khol; Pheak Chhoun; Siyan Yi
Journal:  AIDS Res Ther       Date:  2018-11-17       Impact factor: 2.250

5.  Health-related quality of life among people living with HIV/AIDS in Togo: individuals and contextual effects.

Authors:  Issifou Yaya; Lihanimpo Djalogue; Akouda Akessiwè Patassi; Dadja Essoya Landoh; Ayélé Assindo; Aboubakari Nambiema; Kanfitine Kolani; P'Niwè Massoubayo Patchali; Essodjèlouna Manani Bignandi; Abdoulahy Diallo; Didier Koumavi Ekouévi; Bayaki Saka
Journal:  BMC Res Notes       Date:  2019-03-15

6.  Virologic and immunologic responses of patients on highly active antiretroviral therapy in a rural community health centre in Limpopo, South Africa: A retrospective study.

Authors:  Aniekan Edet; Henry Akinsola; Pascal O Bessong
Journal:  South Afr J HIV Med       Date:  2019-05-22       Impact factor: 2.744

7.  Factors associated with virological non-suppression among HIV-positive children receiving antiretroviral therapy at the Joint Clinical Research Centre in Lubowa, Kampala Uganda.

Authors:  Sarah Nabukeera; Joseph Kagaayi; Fredrick Edward Makumbi; Henry Mugerwa; Joseph K B Matovu
Journal:  PLoS One       Date:  2021-01-27       Impact factor: 3.240

8.  Socio-economic condition and lack of virological suppression among adults and adolescents receiving antiretroviral therapy in Ethiopia.

Authors:  Martin Plymoth; Eduard J Sanders; Elise M Van Der Elst; Patrik Medstrand; Fregenet Tesfaye; Niclas Winqvist; Taye Balcha; Per Björkman
Journal:  PLoS One       Date:  2020-12-15       Impact factor: 3.240

9.  Reaching underserved South Africans with integrated chronic disease screening and mobile HIV counselling and testing: A retrospective, longitudinal study conducted in Cape Town.

Authors:  Philip John Smith; Dvora Joseph Davey; Hunter Green; Morna Cornell; Linda-Gail Bekker
Journal:  PLoS One       Date:  2021-05-04       Impact factor: 3.240

10.  Association between HIV stigma and antiretroviral therapy adherence among adults living with HIV: baseline findings from the HPTN 071 (PopART) trial in Zambia and South Africa.

Authors:  Harriet S Jones; Sian Floyd; Anne Stangl; Virginia Bond; Graeme Hoddinott; Triantafyllos Pliakas; Justin Bwalya; Nomtha Mandla; Ayana Moore; Deborah Donnell; Peter Bock; Sarah Fidler; Richard Hayes; Helen Ayles; James R Hargreaves
Journal:  Trop Med Int Health       Date:  2020-08-26       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.